You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 102850


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 102850

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 26, 2035 Kalvista EKTERLY sebetralstat
⤷  Get Started Free Nov 26, 2035 Kalvista EKTERLY sebetralstat
⤷  Get Started Free Nov 26, 2035 Kalvista EKTERLY sebetralstat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR102850

Last updated: September 7, 2025

Introduction

Patent AR102850 pertains to a pharmaceutical invention filed in Argentina. A comprehensive understanding of its scope, claims, and the patent landscape is vital for stakeholders including pharmaceutical companies, generic manufacturers, legal professionals, and research entities. This analysis investigates the patent’s specific claims, its positioning within Argentina's intellectual property framework, and the broader patent environment influencing its valuation and competitive landscape.

Overview of Patent AR102850

AR102850 was granted by the National Institute of Industrial Property (INPI) of Argentina, reflecting the country's adherence to intellectual property rights (IPR) standards aligned with international agreements such as the TRIPS Agreement. The patent pertains to a novel pharmaceutical compound or formulation, with claims likely directed towards the compound itself, its methods of synthesis, and therapeutic applications.

While the specific patent document details are proprietary, typical pharmaceutical patent claims in Argentina follow standard scope conventions—covering composition-of-matter, process, and use claims. The patent's effective term, enforceability, and territorial scope are tied to Argentine law and international patent treaties.

Scope and Claims Analysis

1. Claims Structure

Patent AR102850's claims are structured to provide broad protective coverage, commonly including:

  • Product Claims: Covering the chemical entity, potentially a novel molecule or a pharmaceutically active compound.
  • Method Claims: Detailing methods of synthesis, formulation, or therapeutic use.
  • Use Claims: Claims directed towards specific medical applications, such as treatment of a particular condition.

The scope is typically formulated to balance broad exclusivity with specificity to withstand potential legal challenges or patent invalidation attempts.

2. Key Claims Features

a. Composition-of-Matter Claims

These claims likely cover the claimed chemical compound or its salts, esters, or derivatives. In Argentina, composition claims are primary for pharmaceutical patents and often set the fundamental scope of exclusivity.

b. Method of Manufacturing

Claims describing the synthesis pathway defend against generic manufacturing and might specify novel intermediates or steps contributing to inventive activity.

c. Therapeutic Use

Use claims specify the medical indications for the compound, potentially broadening patent scope by protecting multiple therapeutic applications.

d. Formulation Claims

Claims may extend to specific formulations, such as sustained-release matrices, combinations with other agents, or delivery systems, offering additional layer of protection.

3. Patent Claims Language Dynamics

The claims utilize precise chemical nomenclature and functional language referencing the compound's structure, activity, and therapeutic effects. They are designed to meet Argentine patent law standards, which favor clarity and support for inventive step and industrial application.

4. Limitations and Potential Challenges

  • Prior Art Considerations: Argentine patent law emphasizes novelty and inventive step. Existing patents or publications—both domestic and international—could limit scope if overlaps exist.
  • Lack of broad functional claims: Argentine courts often scrutinize overly broad claims, especially if they lack sufficient disclosure or inventive step.
  • Novelty reinstatement: The patent’s claims may be challenged if similar compounds are documented prior to filing.

Patent Landscape in Argentina

1. Domestic and International Patent Activity

Argentina's pharmaceutical patent landscape is characterized by:

  • Limited domestic filings: Historically, Argentina has relatively fewer patent applications for pharmaceuticals due to patent term delays and local market considerations.
  • International influence: Catalyzed by Argentina’s membership in the Patent Cooperation Treaty (PCT) and TRIPS, most innovative pharma companies file patent applications abroad, with some seeking national protection.

Key Patent Areas:

  • Novel chemical entities
  • Formulation innovations
  • Method of use and treatment methods

2. Competitive Landscape

Patent AR102850’s landscape involves:

  • Potential prior art searches revealing similar compounds or use claims.
  • Patents filed in other jurisdictions impacting Argentina’s patentability landscape, especially in countries with harmonized patent standards such as Brazil, the US, and Europe.

Patent families surrounding AR102850 indicate strategic protection extending to regional markets, especially Latin America, where patent rights can influence market exclusivity.

3. Patent Validity and Enforcement

Argentina’s Patent Law (Ley de Patentes Nº 24,481) emphasizes strict criteria for novelty, inventive step, and industrial application. The validity of AR102850, therefore, hinges on demonstrating:

  • Novelty over prior art
  • Inventive step amidst existing compounds and methods
  • Sufficient disclosure

Enforcement measures are governed by Argentine civil and criminal laws, providing enforcement avenues against infringing parties.

Legal and Commercial Implications

  • An enforceable patent enhances market exclusivity, deterring generic entry.
  • Narrow claims may limit exclusivity but provide defensibility.
  • Broader claims could heighten risk of litigation or invalidation, especially if challenged by prior art.

Strategic Recommendations

Stakeholders should monitor subsequent patent filings, especially design-around strategies, and challenge proceedings. Commercial entities should assess the patent’s scope for licensing, partnerships, or entry timing.

Key Takeaways

  • Claim Breadth: Patent AR102850 likely includes composition, method, and use claims, with scope tailored to balance broad protection and enforceability under Argentine law.
  • Landscape Dynamics: The patent exists within a competitive environment characterized by domestic and international filings. Its strength depends on prior art landscaping and claim drafting quality.
  • Legal Protections: Argentina’s patent law offers robust enforceability, but claims must withstand scrutiny on novelty and inventive step.
  • Strategic Considerations: Expanding patent scope through family filings and supplementary protections can mitigate risks and enhance exclusivity.
  • Market Impact: Effective patent protection under AR102850 can secure a competitive edge in Argentina’s pharmaceutical market, especially given the country's ongoing alignment with global IPR standards.

FAQs

1. What is the typical scope of pharmaceutical patents in Argentina?
Pharmaceutical patents in Argentina generally cover the chemical composition, manufacturing process, and therapeutic use of the compound. The scope depends on how broadly the claims are drafted and supported by the disclosure.

2. How does Argentine patent law impact the validity of AR102850?
Argentina requires patents to demonstrate novelty, inventive step, and industrial applicability. The validity of AR102850 depends on satisfying these criteria and surviving potential prior art challenges.

3. Can claims in AR102850 be extended or modified post-grant?
While the scope of granted claims is generally fixed, patentees can file divisional applications or seek amendments during prosecution or patent term extensions, subject to Argentine law.

4. What role does patent landscaping play for AR102850?
Patents in the same landscape can influence the patent’s strength, scope, and potential for infringement or invalidation. Landscape analysis informs strategy, including licensing and litigation.

5. How does Argentina's patent environment compare regionally?
Argentina’s patent environment aligns with international standards but has fewer pharmaceutical patents compared to Brazil or the US. Regional collaborations and harmonization efforts influence strategic positioning.

References

  1. INPI Argentina. Patent Laws and Official Guidelines.
  2. World Intellectual Property Organization (WIPO). Patent landscape reports on Latin America.
  3. Argentine Patent Law (Ley de Patentes Nº 24,481).
  4. Patent Office Filings and Publications.
  5. Legal analyses on pharmaceutical patent strategies in Latin America.

This comprehensive review equips stakeholders with a detailed understanding of the scope, claims, and landscape surrounding Argentine patent AR102850, informing strategic decisions in pharmaceutical innovation and intellectual property management.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.